期刊文献+

抑肝扶脾法治疗肠易激综合征之腹痛腹泻症 被引量:7

Represses the Liver and Strengthen the Spleen the Law Treatment Intestines Easily to Stir up the Synthesis to Draft the Abdominal Pain Diarrhea Sickness
下载PDF
导出
摘要 目的:评价中医抑肝扶脾法治疗肠易激综合征(IBS)之腹痛腹泻症的治疗作用。方法:将40例符合罗马Ⅱ诊断标准的腹泻型IBS患者,随机分为治疗组23例与对照组17例。两组均给予复方地芬诺脂片口服,治疗组同时煎服抑肝扶脾的痛泻要方加味,观察两组患者总体症状的疗效并进行安全性评估。2周后评定。结果:治疗组临床治愈4例,总有效率91.30%;对照组临床治愈1例,总有效率52.94%,两组比较,差异有显著性(P<0.05)。结论:加用中医药的治疗组疗效明显优于对照组,抑肝扶脾法治疗腹泻型肠易激综合征能有效缓解腹泻、腹胀、腹痛、情绪障碍等主要症状。 Objective:The appraisal Chinese medicine represses the liver and strengthen the spleen the law treatment intestines easily to stir up the synthesis to draft abdominal pain of diarrhea sickness treatment function the(IBS).Methods:Conforms to Rome 40 examplesⅡThe diagnosis standarddiarrhea IBS patient,divides into the treatment group 23 examples and the control group 17 examples stochastically.Two groups give the compound prescription Fenno fat piece oral administration,the treatment group simultaneously fry the pain which the clothing represses the liver and strengthen the spleen to flow swiftly want Fang Jiawei,observes two group of patient overall symptom the curative effect and carries on the secure appraisal.After 2 weeks evaluates.Results:The treatment group clinical cures 4 examples,The total effective rate 91.30%;control group,clinical cure Example 1,the total effective rate 52.94%.Comparing the two groups,there was a significant difference(P0.05).Conclusion:Treatment with Chinese medicine group,curative effect.Represses the liver and strengthen the spleen the law treatment diarrhea intestines easily to stir up the synthesis to draft can alleviate the diarrhea,the distension of the abdomen,the abdominal pain,the mood barrier effectively and so on the main symptom.
作者 冯一
出处 《辽宁中医杂志》 CAS 北大核心 2010年第2期288-289,共2页 Liaoning Journal of Traditional Chinese Medicine
关键词 肠易激综合征 治疗方法 中医药 the intestines easy to stir up the synthesis to draft method of treatment Chinese medicine
  • 相关文献

参考文献4

二级参考文献31

  • 1[1]Drossman DA.[J]. Gut, 1999,45(Suppl Ⅱ ): Ⅱ 1-Ⅱ5.
  • 2[2]Clouse RE, Richter JE, Heading RC.[J]. Gut,1999,45(Suppl Ⅱ ): Ⅱ31-Ⅱ36.
  • 3[3]Moser G, Wenzel-Abatzi TA, Stelzeneder M.[J].Arch Intern Med, 1998,158:1365-1373.
  • 4[4]Rao SSC, Gregersen H, Hayek B.[J]. Ann Intern Med, 1996,124:950-958.
  • 5[5]Fass R, Fennerty MB, Ofman JJ.[J]. Gastroenterology, 1988,115:42-49.
  • 6[6]Watson RGP, Tham TCK, Johnston BT.[J]. Gut,1997,40: 587-590.
  • 7[7]Talley NJ, Stanghellini S, Heading RC.[J]. Gut,1999,45(Suppl Ⅱ ): Ⅱ37-Ⅱ42.
  • 8[8]Talley NJ, SilversteinM, Agreus L.[J]. Gastroenterology, 1998,114:582-595.
  • 9[9]Tack J, Piessevaux H, 'Coulie B.[J]. Gastroenterology, 1998,115:1586-1587.
  • 10[10]Talley NJ, Meineche-Schmidt V, Pare P.[J]. Aliment Pharmacol Ther, 1998,12:1055-1065.

共引文献360

同被引文献56

引证文献7

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部